{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:09:26Z","timestamp":1790813366260,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673282"],"award-info":[{"award-number":["81673282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903430"],"award-info":[{"award-number":["81903430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973159"],"award-info":[{"award-number":["81973159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["lzujbky-2017-133"],"award-info":[{"award-number":["lzujbky-2017-133"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["lzujbky-2018-ot02"],"award-info":[{"award-number":["lzujbky-2018-ot02"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejphar.2020.173169","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T08:52:11Z","timestamp":1589359931000},"page":"173169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Spinal administration of the multi-functional opioid\/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia"],"prefix":"10.1016","volume":"880","author":[{"given":"Run","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangtai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173169_bib1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.pmn.2018.05.005","article-title":"Postoperative pain management: a bedside perspective","volume":"19","author":"Bach","year":"2018","journal-title":"Pain Manag. Nurs."},{"key":"10.1016\/j.ejphar.2020.173169_bib2","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.pain.2012.01.016","article-title":"Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia","volume":"153","author":"Cobos","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173169_bib3","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1097\/j.pain.0000000000001262","article-title":"A bifunctional-biased mu-opioid agonist-neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects","volume":"159","author":"Drieu la Rochelle","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173169_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pmn.2007.02.004","article-title":"Mechanisms of opioid-induced tolerance and hyperalgesia","volume":"8","author":"DuPen","year":"2007","journal-title":"Pain Manag. Nurs."},{"key":"10.1016\/j.ejphar.2020.173169_bib5","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1073\/pnas.130181897","article-title":"A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic","volume":"97","author":"Foran","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173169_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1476-5381.1996.tb15217.x","article-title":"Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues","volume":"117","author":"Gouarderes","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173169_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(93)90095-Y","article-title":"Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat","volume":"237","author":"Gouarderes","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173169_bib8","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.peptides.2008.09.013","article-title":"Lack of tolerance and morphine-induced cross-tolerance to the analgesia of chimeric peptide of Met-enkephalin and FMRFa","volume":"29","author":"Gupta","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2020.173169_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0024-3205(03)00390-4","article-title":"Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain","volume":"73","author":"Hruby","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.173169_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173169_bib11","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00002508-200207001-00002","article-title":"Clinical pharmacology of opioids for pain","volume":"18","author":"Inturrisi","year":"2002","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.ejphar.2020.173169_bib12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.mayocp.2015.04.010","article-title":"Opioid analgesics","volume":"90","author":"Jamison","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejphar.2020.173169_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pain.2010.06.010","article-title":"Targeting microglial purinergic signaling to improve morphine analgesia","volume":"150","author":"Ji","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173169_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/jpet.109.164384","article-title":"Neuropeptide FF receptors have opposing modulatory effects on nociception","volume":"334","author":"Lameh","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173169_bib15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1476-5381.2010.00824.x","article-title":"Spinal or systemic TY005, a peptidic opioid agonist\/neurokinin 1 antagonist, attenuates pain with reduced tolerance","volume":"161","author":"Largent-Milnes","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173169_bib16","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/bph.13489","article-title":"BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice","volume":"173","author":"Li","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173169_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2018.08.039","article-title":"Systemic administration of the bifunctional opioid\/neuropeptide FF receptors agonist BN-9 produced peripheral antinociception in preclinical mouse models of pain","volume":"837","author":"Li","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173169_bib18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ejp.814","article-title":"Altered nociception and morphine tolerance in neuropeptide FF receptor type 2 over-expressing mice","volume":"20","author":"Lin","year":"2016","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2020.173169_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2017.02.003","article-title":"Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory mediator CGRP in mice","volume":"291","author":"Lin","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2020.173169_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2014.10.018","article-title":"Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions","volume":"584","author":"Malin","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2020.173169_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1526-4637.2012.01438.x","article-title":"Ankle joint mobilization decreases hypersensitivity by activation of peripheral opioid receptors in a mouse model of postoperative pain","volume":"13","author":"Martins","year":"2012","journal-title":"Pain Med."},{"key":"10.1016\/j.ejphar.2020.173169_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/biof.116","article-title":"Opioid-modulating properties of the neuropeptide FF system","volume":"36","author":"Mouledous","year":"2010","journal-title":"Biofactors"},{"key":"10.1016\/j.ejphar.2020.173169_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/cns.12486","article-title":"Preclinical assessment of inflammatory pain","volume":"22","author":"Muley","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2020.173169_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejps.2015.11.015","article-title":"Co-administration of morphine and gabapentin leads to dose dependent synergistic effects in a rat model of postoperative pain","volume":"82","author":"Papathanasiou","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2020.173169_bib25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.06.029","article-title":"Opioid-induced hyperalgesia: cellular and molecular mechanisms","volume":"338","author":"Roeckel","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2020.173169_bib26","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.lfs.2009.02.025","article-title":"Bi- or multifunctional opioid peptide drugs","volume":"86","author":"Schiller","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.173169_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2013.01.076","article-title":"Opioids, sensory systems and chronic pain","volume":"716","author":"Stein","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173169_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.intimp.2018.05.034","article-title":"Attenuation of inflammatory pain by puerarin in animal model of inflammation through inhibition of pro-inflammatory mediators","volume":"61","author":"Ullah","year":"2018","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2020.173169_bib29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0304-3959(99)00158-X","article-title":"Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats","volume":"83","author":"Walker","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173169_bib30","article-title":"Spinal DN-9, a peptidic multifunctional opioid\/neuropeptide FF agonist produced potent nontolerance forming analgesia with limited side effects","author":"Wang","year":"2019","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2020.173169_bib31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2016.03.017","article-title":"Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance","volume":"108","author":"Wang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173169_bib32","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1021\/acs.jmedchem.6b01181","article-title":"Structure-based optimization of multifunctional agonists for opioid and neuropeptide FF receptors with potent nontolerance forming analgesic activities","volume":"59","author":"Wang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173169_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneumeth.2003.09.015","article-title":"Chronic lumbar catheterization of the spinal subarachnoid space in mice","volume":"133","author":"Wu","year":"2004","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2020.173169_bib34","article-title":"The multifunctional peptide DN\u20109 produced peripherally acting antinociception in inflammatory and neuropathic pain via mu and kappa opioid receptors","author":"Xu","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173169_bib35","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1073\/pnas.82.22.7757","article-title":"Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine","volume":"82","author":"Yang","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173169_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejphar.2017.07.044","article-title":"Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid\/NPFF receptors agonist BN-9 in inflammatory pain model","volume":"813","author":"Zhang","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173169_bib37","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bmc.2019.01.003","article-title":"Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: synthesis and neuropharmacological evaluation","volume":"27","author":"Zhang","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173169_bib38","article-title":"ERK MAP kinase activation in spinal cord regulates phosphorylation of Cdk5 at serine 159 and contributes to peripheral inflammation induced pain\/hypersensitivity","volume":"9","author":"Zhang","year":"2014","journal-title":"PloS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:37:48Z","timestamp":1757975868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920302612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":38,"alternative-id":["S0014299920302612"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173169","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinal administration of the multi-functional opioid\/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173169"}}